Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

The scheme aims to deliver affordable generic drugs, which can be 50-80% cheaper than branded varieties, but has been hobbled ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

Daniels says the shortage of brand name drugs like glucagon-like peptide-1 (GLP-1) medications to treat diabetes and obesity ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

The Kobe University start-up Photo-on-Demand Chemical Co. Ltd. demonstrated that it can produce methane from sewage to refine ...